MetLife, Inc. $MET Shares Bought by Evergreen Capital Management LLC

Evergreen Capital Management LLC boosted its stake in shares of MetLife, Inc. (NYSE:MET) by 195.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 33,260 shares of the financial services provider’s stock after buying an additional 22,016 shares during the period. Evergreen Capital Management LLC’s holdings in MetLife were worth $2,626,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Providence Capital Advisors LLC acquired a new position in MetLife during the third quarter worth $6,649,000. Thrivent Financial for Lutherans boosted its stake in MetLife by 8.9% during the third quarter. Thrivent Financial for Lutherans now owns 1,176,469 shares of the financial services provider’s stock worth $96,905,000 after buying an additional 96,523 shares during the last quarter. Nordea Investment Management AB lifted its holdings in MetLife by 2.6% in the fourth quarter. Nordea Investment Management AB now owns 4,630,165 shares of the financial services provider’s stock valued at $366,524,000 after acquiring an additional 117,545 shares during the last quarter. Varma Mutual Pension Insurance Co lifted its holdings in MetLife by 21.9% in the third quarter. Varma Mutual Pension Insurance Co now owns 137,956 shares of the financial services provider’s stock valued at $11,363,000 after acquiring an additional 24,800 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. lifted its holdings in MetLife by 256.8% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 62,662 shares of the financial services provider’s stock valued at $5,161,000 after acquiring an additional 45,100 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Down 0.7%

NYSE:MET opened at $76.94 on Thursday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The stock’s fifty day moving average is $73.11 and its two-hundred day moving average is $76.72. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $83.85. The stock has a market capitalization of $50.17 billion, a price-to-earnings ratio of 16.37, a price-to-earnings-growth ratio of 0.69 and a beta of 0.74.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The company had revenue of $52.44 billion for the quarter, compared to analysts’ expectations of $31.43 billion. During the same period in the prior year, the firm earned $2.08 earnings per share. The firm’s revenue was up 27.6% compared to the same quarter last year. Research analysts anticipate that MetLife, Inc. will post 9.85 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Bank of America decreased their price objective on MetLife from $103.00 to $99.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. TD Cowen decreased their price objective on MetLife from $91.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, March 11th. Evercore set a $96.00 price objective on MetLife in a report on Thursday, April 9th. Morgan Stanley decreased their price objective on MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Finally, UBS Group upped their price objective on MetLife from $98.00 to $102.00 and gave the company a “buy” rating in a report on Thursday, April 9th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and a consensus target price of $93.38.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.